Keratinocyte growth factor (KGF; palifermin or repifermin), intravenous vs placebo
Normalcy of diet (mean worst ability to eat, 1 to 4 scale) · Adults with cancer receiving treatment
Keratinocyte growth factor (KGF; palifermin or repifermin),… showed no clear difference in normalcy of diet (mean worst ability to eat, 1 to 4 scale) compared with placebo; GRADE not reported.
1 finding from 1 review
- Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors 2017 · Cochrane All outcomesBMT/SCT after conditioning for haematological cancersMD -0.50 [-1.21, 0.21]1 study · 42 participantsGRADE not reported